

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.71982686 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.41597415 |
| 3 | axon ensheathment in central nervous system (GO:0032291) | 5.29653824 |
| 4 | central nervous system myelination (GO:0022010) | 5.29653824 |
| 5 | locomotory exploration behavior (GO:0035641) | 5.29498391 |
| 6 | layer formation in cerebral cortex (GO:0021819) | 5.16459281 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.06117164 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.57775417 |
| 9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.52799526 |
| 10 | presynaptic membrane assembly (GO:0097105) | 4.49657322 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.47138173 |
| 12 | vocalization behavior (GO:0071625) | 4.46900898 |
| 13 | regulation of synapse structural plasticity (GO:0051823) | 4.30398423 |
| 14 | dendritic spine morphogenesis (GO:0060997) | 4.28983620 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 4.23226031 |
| 16 | nucleobase catabolic process (GO:0046113) | 4.13683761 |
| 17 | glutamate secretion (GO:0014047) | 4.07376980 |
| 18 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.03783333 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.99992070 |
| 20 | exploration behavior (GO:0035640) | 3.92689585 |
| 21 | protein localization to synapse (GO:0035418) | 3.80584721 |
| 22 | dendrite morphogenesis (GO:0048813) | 3.80474873 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 3.79703972 |
| 24 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.76934531 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.73857850 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.72246564 |
| 27 | sodium ion export (GO:0071436) | 3.69050146 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.62990536 |
| 29 | cell migration in hindbrain (GO:0021535) | 3.62350010 |
| 30 | neuron recognition (GO:0008038) | 3.60337577 |
| 31 | regulation of synaptic vesicle transport (GO:1902803) | 3.54242150 |
| 32 | proline transport (GO:0015824) | 3.47068129 |
| 33 | axonal fasciculation (GO:0007413) | 3.44052164 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 3.41021974 |
| 35 | clathrin coat assembly (GO:0048268) | 3.40300739 |
| 36 | neurotransmitter secretion (GO:0007269) | 3.39001910 |
| 37 | establishment of nucleus localization (GO:0040023) | 3.38856051 |
| 38 | neuromuscular process controlling balance (GO:0050885) | 3.33673297 |
| 39 | glycine transport (GO:0015816) | 3.32319396 |
| 40 | regulation of ARF protein signal transduction (GO:0032012) | 3.30538956 |
| 41 | neuronal action potential propagation (GO:0019227) | 3.30325921 |
| 42 | amino acid import (GO:0043090) | 3.29663093 |
| 43 | positive regulation of synapse maturation (GO:0090129) | 3.24722078 |
| 44 | activation of protein kinase A activity (GO:0034199) | 3.20074658 |
| 45 | glutamate receptor signaling pathway (GO:0007215) | 3.14781536 |
| 46 | synaptic transmission, glutamatergic (GO:0035249) | 3.14367711 |
| 47 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.12250537 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.11747294 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.11591879 |
| 50 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.10343874 |
| 51 | gamma-aminobutyric acid transport (GO:0015812) | 3.07821466 |
| 52 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.06846611 |
| 53 | nerve growth factor signaling pathway (GO:0038180) | 3.06638120 |
| 54 | long-term memory (GO:0007616) | 3.06365573 |
| 55 | synaptic vesicle endocytosis (GO:0048488) | 3.04363487 |
| 56 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02939672 |
| 57 | auditory behavior (GO:0031223) | 3.02066885 |
| 58 | regulation of synapse maturation (GO:0090128) | 3.01903413 |
| 59 | negative regulation of microtubule polymerization (GO:0031115) | 3.00530425 |
| 60 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.98072534 |
| 61 | cell communication by electrical coupling (GO:0010644) | 2.95524576 |
| 62 | response to auditory stimulus (GO:0010996) | 2.95443053 |
| 63 | L-amino acid import (GO:0043092) | 2.94348582 |
| 64 | mechanosensory behavior (GO:0007638) | 2.93787858 |
| 65 | neuromuscular synaptic transmission (GO:0007274) | 2.91542554 |
| 66 | neuronal ion channel clustering (GO:0045161) | 2.91465408 |
| 67 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.90152303 |
| 68 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.89348525 |
| 69 | positive regulation of membrane potential (GO:0045838) | 2.85431101 |
| 70 | cerebellar Purkinje cell layer development (GO:0021680) | 2.84758685 |
| 71 | regulation of ARF GTPase activity (GO:0032312) | 2.84570307 |
| 72 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.84336381 |
| 73 | neuron-neuron synaptic transmission (GO:0007270) | 2.83044675 |
| 74 | potassium ion import (GO:0010107) | 2.81775643 |
| 75 | establishment of mitochondrion localization (GO:0051654) | 2.81588289 |
| 76 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.80726287 |
| 77 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.80353145 |
| 78 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.79939813 |
| 79 | organelle transport along microtubule (GO:0072384) | 2.79570148 |
| 80 | regulation of synaptic plasticity (GO:0048167) | 2.79138786 |
| 81 | prepulse inhibition (GO:0060134) | 2.78609374 |
| 82 | vesicle transport along microtubule (GO:0047496) | 2.77390900 |
| 83 | positive regulation of dendritic spine development (GO:0060999) | 2.77194511 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.75828841 |
| 85 | cellular response to monoamine stimulus (GO:0071868) | 2.75474080 |
| 86 | cellular response to catecholamine stimulus (GO:0071870) | 2.75474080 |
| 87 | regulation of postsynaptic membrane potential (GO:0060078) | 2.74953345 |
| 88 | positive regulation of synapse assembly (GO:0051965) | 2.74570817 |
| 89 | regulation of dendritic spine development (GO:0060998) | 2.74443018 |
| 90 | regulation of neurotransmitter levels (GO:0001505) | 2.73758852 |
| 91 | regulation of respiratory system process (GO:0044065) | 2.73406538 |
| 92 | cerebellar granule cell differentiation (GO:0021707) | 2.73351437 |
| 93 | axon extension (GO:0048675) | 2.73129435 |
| 94 | dendritic spine organization (GO:0097061) | 2.72101848 |
| 95 | membrane depolarization during action potential (GO:0086010) | 2.71817653 |
| 96 | neurotransmitter transport (GO:0006836) | 2.70711007 |
| 97 | regulation of neurotransmitter transport (GO:0051588) | 2.69958568 |
| 98 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.68243899 |
| 99 | potassium ion homeostasis (GO:0055075) | 2.67471513 |
| 100 | postsynaptic membrane organization (GO:0001941) | 2.66863985 |
| 101 | transmission of nerve impulse (GO:0019226) | 2.66652401 |
| 102 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.64780771 |
| 103 | astrocyte development (GO:0014002) | 2.64273682 |
| 104 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.63595005 |
| 105 | negative regulation of axonogenesis (GO:0050771) | 2.63398683 |
| 106 | membrane assembly (GO:0071709) | 2.63335886 |
| 107 | regulation of neurotransmitter secretion (GO:0046928) | 2.63161435 |
| 108 | adult walking behavior (GO:0007628) | 2.62752852 |
| 109 | cell-cell junction maintenance (GO:0045217) | 2.62122272 |
| 110 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.60889811 |
| 111 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.60719724 |
| 112 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.56526716 |
| 113 | mitochondrion transport along microtubule (GO:0047497) | 2.56526716 |
| 114 | neuron projection morphogenesis (GO:0048812) | 2.55356902 |
| 115 | synapse organization (GO:0050808) | 2.54875000 |
| 116 | positive regulation of fibroblast migration (GO:0010763) | 2.53941010 |
| 117 | synapse assembly (GO:0007416) | 2.52555184 |
| 118 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.52412325 |
| 119 | axon cargo transport (GO:0008088) | 2.52017176 |
| 120 | presynaptic membrane organization (GO:0097090) | 2.51749031 |
| 121 | membrane hyperpolarization (GO:0060081) | 2.51618930 |
| 122 | glial cell proliferation (GO:0014009) | 2.51388719 |
| 123 | neuromuscular process (GO:0050905) | 2.51025735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.94298730 |
| 2 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.75981668 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.73664792 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68138809 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.66805412 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.63021239 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.63021239 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.56249666 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.54807935 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.39317136 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.36694914 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30123931 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.24419765 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.22952197 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.22520266 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21763934 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.21269439 |
| 18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.21049687 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.18650128 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.17777200 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16488115 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.15099418 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.98422696 |
| 24 | KDM2B_26808549_Chip-Seq_K562_Human | 1.92529565 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87436023 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86889540 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85471067 |
| 28 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.84803056 |
| 29 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.83779285 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82697284 |
| 31 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.79071746 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.75276629 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.74959611 |
| 34 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.65940657 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.60670301 |
| 36 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.58172320 |
| 37 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.54313654 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.53435194 |
| 39 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.52174958 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.52034664 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.51012777 |
| 42 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48353236 |
| 43 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48339690 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.48012706 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47963198 |
| 46 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.47954369 |
| 47 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.44994972 |
| 48 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.42728488 |
| 49 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.41235157 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.37531767 |
| 51 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.34393556 |
| 52 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.33493116 |
| 53 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27186607 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26500615 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25868152 |
| 56 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19259846 |
| 57 | AR_19668381_ChIP-Seq_PC3_Human | 1.18542561 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.17270550 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.16342746 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16333522 |
| 61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.15147282 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.14901275 |
| 63 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14845275 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14773034 |
| 65 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.13754980 |
| 66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12050822 |
| 67 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11934650 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11554337 |
| 69 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.10920817 |
| 70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10496855 |
| 71 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07143240 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06616270 |
| 73 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04968524 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.04779217 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04290926 |
| 76 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.02992247 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.01478665 |
| 78 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.01412878 |
| 79 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00192295 |
| 80 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00000530 |
| 81 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99616072 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98704395 |
| 83 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.98370895 |
| 84 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98192819 |
| 85 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97910548 |
| 86 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97591342 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.97221650 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96654646 |
| 89 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.96592920 |
| 90 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96325203 |
| 91 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96290221 |
| 92 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95041995 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94403550 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93926999 |
| 95 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.93696324 |
| 96 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91164098 |
| 97 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90928193 |
| 98 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.90843669 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90132495 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.90021697 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.89291550 |
| 102 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88851604 |
| 103 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88749660 |
| 104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88711736 |
| 105 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88533975 |
| 106 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88069150 |
| 107 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88057030 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88057030 |
| 109 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.87869002 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86815413 |
| 111 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.86109582 |
| 112 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85725459 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85112262 |
| 114 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.84467313 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84382130 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.84130052 |
| 117 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.84079872 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82361024 |
| 119 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.81184828 |
| 120 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78087579 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.42170824 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.73101124 |
| 3 | MP0003880_abnormal_central_pattern | 3.54803134 |
| 4 | MP0004270_analgesia | 3.50161640 |
| 5 | MP0005423_abnormal_somatic_nervous | 3.07712354 |
| 6 | MP0002063_abnormal_learning/memory/cond | 2.93592267 |
| 7 | MP0002064_seizures | 2.74117672 |
| 8 | MP0009745_abnormal_behavioral_response | 2.70762545 |
| 9 | MP0004858_abnormal_nervous_system | 2.56240468 |
| 10 | MP0000778_abnormal_nervous_system | 2.48290260 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.40772248 |
| 12 | MP0009046_muscle_twitch | 2.33391976 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.33325138 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.22072208 |
| 15 | MP0001486_abnormal_startle_reflex | 2.21678221 |
| 16 | MP0000569_abnormal_digit_pigmentation | 2.18551727 |
| 17 | MP0008569_lethality_at_weaning | 2.07272983 |
| 18 | MP0002272_abnormal_nervous_system | 2.04776500 |
| 19 | MP0004811_abnormal_neuron_physiology | 2.01935463 |
| 20 | MP0004885_abnormal_endolymph | 2.00770086 |
| 21 | MP0003329_amyloid_beta_deposits | 1.99716807 |
| 22 | MP0002733_abnormal_thermal_nociception | 1.95234042 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.89686865 |
| 24 | MP0001970_abnormal_pain_threshold | 1.82439970 |
| 25 | MP0000955_abnormal_spinal_cord | 1.80499253 |
| 26 | MP0002184_abnormal_innervation | 1.74731677 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.73547034 |
| 28 | MP0000920_abnormal_myelination | 1.71754442 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.68379715 |
| 30 | MP0002736_abnormal_nociception_after | 1.68142505 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.64386210 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.63378608 |
| 33 | MP0002882_abnormal_neuron_morphology | 1.55772243 |
| 34 | MP0002822_catalepsy | 1.46818873 |
| 35 | MP0003633_abnormal_nervous_system | 1.46377168 |
| 36 | MP0000751_myopathy | 1.46322147 |
| 37 | MP0003634_abnormal_glial_cell | 1.44131062 |
| 38 | MP0005386_behavior/neurological_phenoty | 1.43693087 |
| 39 | MP0004924_abnormal_behavior | 1.43693087 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.41118068 |
| 41 | MP0002066_abnormal_motor_capabilities/c | 1.37007844 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.36305530 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.36188858 |
| 44 | MP0002152_abnormal_brain_morphology | 1.34896889 |
| 45 | MP0003690_abnormal_glial_cell | 1.33793379 |
| 46 | MP0003303_peritoneal_inflammation | 1.29541315 |
| 47 | MP0003787_abnormal_imprinting | 1.28377141 |
| 48 | MP0008961_abnormal_basal_metabolism | 1.27595509 |
| 49 | MP0003631_nervous_system_phenotype | 1.26270526 |
| 50 | MP0003121_genomic_imprinting | 1.22253845 |
| 51 | MP0002638_abnormal_pupillary_reflex | 1.16841966 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.16389928 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.08476230 |
| 54 | MP0001299_abnormal_eye_distance/ | 1.06797760 |
| 55 | MP0003938_abnormal_ear_development | 1.06743379 |
| 56 | MP0004742_abnormal_vestibular_system | 1.05816904 |
| 57 | MP0002653_abnormal_ependyma_morphology | 1.05547753 |
| 58 | MP0000026_abnormal_inner_ear | 1.04238169 |
| 59 | MP0003632_abnormal_nervous_system | 1.01698707 |
| 60 | MP0004510_myositis | 1.00614054 |
| 61 | MP0001485_abnormal_pinna_reflex | 0.99397710 |
| 62 | MP0003122_maternal_imprinting | 0.99236559 |
| 63 | MP0003861_abnormal_nervous_system | 0.99088780 |
| 64 | MP0000747_muscle_weakness | 0.99022261 |
| 65 | MP0005646_abnormal_pituitary_gland | 0.99018767 |
| 66 | MP0003879_abnormal_hair_cell | 0.97870851 |
| 67 | MP0004130_abnormal_muscle_cell | 0.97411330 |
| 68 | MP0005187_abnormal_penis_morphology | 0.96613512 |
| 69 | MP0003123_paternal_imprinting | 0.95097836 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.94525835 |
| 71 | MP0001502_abnormal_circadian_rhythm | 0.93848269 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.93738623 |
| 73 | MP0004142_abnormal_muscle_tone | 0.93605924 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.93129093 |
| 75 | MP0005499_abnormal_olfactory_system | 0.93129093 |
| 76 | MP0005645_abnormal_hypothalamus_physiol | 0.92643339 |
| 77 | MP0002229_neurodegeneration | 0.91949313 |
| 78 | MP0003075_altered_response_to | 0.90582697 |
| 79 | MP0005409_darkened_coat_color | 0.90020477 |
| 80 | MP0006276_abnormal_autonomic_nervous | 0.87623655 |
| 81 | MP0004133_heterotaxia | 0.87052668 |
| 82 | MP0000604_amyloidosis | 0.84811658 |
| 83 | MP0001905_abnormal_dopamine_level | 0.84144971 |
| 84 | MP0001177_atelectasis | 0.81975657 |
| 85 | MP0001984_abnormal_olfaction | 0.81192146 |
| 86 | MP0004085_abnormal_heartbeat | 0.81061837 |
| 87 | MP0002089_abnormal_postnatal_growth/wei | 0.79480024 |
| 88 | MP0000631_abnormal_neuroendocrine_gland | 0.79300610 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.78104263 |
| 90 | MP0004233_abnormal_muscle_weight | 0.78022279 |
| 91 | MP0001188_hyperpigmentation | 0.77837088 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.77781267 |
| 93 | MP0002069_abnormal_eating/drinking_beha | 0.76529755 |
| 94 | MP0000049_abnormal_middle_ear | 0.74187767 |
| 95 | MP0001943_abnormal_respiration | 0.73383393 |
| 96 | MP0008874_decreased_physiological_sensi | 0.72357265 |
| 97 | MP0000749_muscle_degeneration | 0.72301273 |
| 98 | MP0000534_abnormal_ureter_morphology | 0.72264192 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 0.72236312 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.71326154 |
| 101 | MP0002090_abnormal_vision | 0.69906340 |
| 102 | MP0003283_abnormal_digestive_organ | 0.69682580 |
| 103 | MP0004484_altered_response_of | 0.67415073 |
| 104 | MP0000566_synostosis | 0.67233034 |
| 105 | MP0001849_ear_inflammation | 0.67001504 |
| 106 | MP0002082_postnatal_lethality | 0.64088997 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.63811837 |
| 108 | MP0003385_abnormal_body_wall | 0.63597494 |
| 109 | MP0001529_abnormal_vocalization | 0.62868824 |
| 110 | MP0010769_abnormal_survival | 0.62355200 |
| 111 | MP0001963_abnormal_hearing_physiology | 0.62201687 |
| 112 | MP0000733_abnormal_muscle_development | 0.61013317 |
| 113 | MP0001346_abnormal_lacrimal_gland | 0.58104466 |
| 114 | MP0002081_perinatal_lethality | 0.58075877 |
| 115 | MP0002102_abnormal_ear_morphology | 0.58031374 |
| 116 | MP0010768_mortality/aging | 0.57531045 |
| 117 | MP0008770_decreased_survivor_rate | 0.57352350 |
| 118 | MP0010770_preweaning_lethality | 0.56866957 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.88757369 |
| 2 | Supranuclear gaze palsy (HP:0000605) | 4.11369647 |
| 3 | Action tremor (HP:0002345) | 4.09368299 |
| 4 | Termporal pattern (HP:0011008) | 3.97388672 |
| 5 | Insidious onset (HP:0003587) | 3.97388672 |
| 6 | Focal motor seizures (HP:0011153) | 3.91510214 |
| 7 | Focal seizures (HP:0007359) | 3.75405853 |
| 8 | Ankle clonus (HP:0011448) | 3.73370313 |
| 9 | Visual hallucinations (HP:0002367) | 3.63192405 |
| 10 | Mutism (HP:0002300) | 3.51955738 |
| 11 | Insomnia (HP:0100785) | 3.23270873 |
| 12 | Polyphagia (HP:0002591) | 3.05002724 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.02865654 |
| 14 | Papilledema (HP:0001085) | 2.94761340 |
| 15 | Abnormality of the corticospinal tract (HP:0002492) | 2.94694518 |
| 16 | Progressive cerebellar ataxia (HP:0002073) | 2.91409884 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 2.89321091 |
| 18 | Epileptic encephalopathy (HP:0200134) | 2.88841218 |
| 19 | Hyperacusis (HP:0010780) | 2.87051584 |
| 20 | Urinary urgency (HP:0000012) | 2.81460814 |
| 21 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.80997573 |
| 22 | Megalencephaly (HP:0001355) | 2.80518690 |
| 23 | Depression (HP:0000716) | 2.77018724 |
| 24 | Scanning speech (HP:0002168) | 2.71045123 |
| 25 | Genetic anticipation (HP:0003743) | 2.65647936 |
| 26 | Poor eye contact (HP:0000817) | 2.58469952 |
| 27 | Spastic gait (HP:0002064) | 2.57829881 |
| 28 | Overriding aorta (HP:0002623) | 2.57005293 |
| 29 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.54224626 |
| 30 | Pointed chin (HP:0000307) | 2.54190670 |
| 31 | Broad-based gait (HP:0002136) | 2.50130885 |
| 32 | Postural instability (HP:0002172) | 2.48007130 |
| 33 | Apathy (HP:0000741) | 2.47439415 |
| 34 | Abnormal social behavior (HP:0012433) | 2.44396867 |
| 35 | Impaired social interactions (HP:0000735) | 2.44396867 |
| 36 | Sleep apnea (HP:0010535) | 2.42195727 |
| 37 | Turricephaly (HP:0000262) | 2.40751700 |
| 38 | Diplopia (HP:0000651) | 2.38314446 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.38314446 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.38010979 |
| 41 | Elfin facies (HP:0004428) | 2.36534436 |
| 42 | Dysmetria (HP:0001310) | 2.34479615 |
| 43 | Split foot (HP:0001839) | 2.34231025 |
| 44 | Fetal akinesia sequence (HP:0001989) | 2.34162230 |
| 45 | Hemiplegia (HP:0002301) | 2.33970665 |
| 46 | Akinesia (HP:0002304) | 2.33670765 |
| 47 | Macroorchidism (HP:0000053) | 2.33360862 |
| 48 | Obstructive sleep apnea (HP:0002870) | 2.32984958 |
| 49 | Truncal ataxia (HP:0002078) | 2.32099582 |
| 50 | Spastic tetraparesis (HP:0001285) | 2.31170601 |
| 51 | Excessive salivation (HP:0003781) | 2.30201939 |
| 52 | Drooling (HP:0002307) | 2.30201939 |
| 53 | Abnormal eating behavior (HP:0100738) | 2.29340290 |
| 54 | Lower limb muscle weakness (HP:0007340) | 2.29285569 |
| 55 | Epileptiform EEG discharges (HP:0011182) | 2.29078900 |
| 56 | Hemiparesis (HP:0001269) | 2.26973587 |
| 57 | Intention tremor (HP:0002080) | 2.26291431 |
| 58 | Inappropriate behavior (HP:0000719) | 2.24226076 |
| 59 | Peripheral hypomyelination (HP:0007182) | 2.20882698 |
| 60 | Onion bulb formation (HP:0003383) | 2.19470472 |
| 61 | Abnormality of the lower motor neuron (HP:0002366) | 2.18840572 |
| 62 | Diminished motivation (HP:0000745) | 2.18564689 |
| 63 | Neuronal loss in central nervous system (HP:0002529) | 2.16469088 |
| 64 | Generalized tonic-clonic seizures (HP:0002069) | 2.15190866 |
| 65 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.15138094 |
| 66 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.15138094 |
| 67 | Rapidly progressive (HP:0003678) | 2.14539012 |
| 68 | EEG with generalized epileptiform discharges (HP:0011198) | 2.14482559 |
| 69 | Hypsarrhythmia (HP:0002521) | 2.14221655 |
| 70 | Febrile seizures (HP:0002373) | 2.13105377 |
| 71 | Vitreoretinal degeneration (HP:0000655) | 2.12542824 |
| 72 | Exercise-induced myalgia (HP:0003738) | 2.11920105 |
| 73 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.11785832 |
| 74 | Anxiety (HP:0000739) | 2.10975065 |
| 75 | Hypoplasia of the corpus callosum (HP:0002079) | 2.10711761 |
| 76 | Stereotypic behavior (HP:0000733) | 2.10030755 |
| 77 | Atonic seizures (HP:0010819) | 2.09216370 |
| 78 | Absence seizures (HP:0002121) | 2.09089417 |
| 79 | Dysdiadochokinesis (HP:0002075) | 2.06938949 |
| 80 | Lower limb amyotrophy (HP:0007210) | 2.06547679 |
| 81 | Torticollis (HP:0000473) | 2.06005571 |
| 82 | Ulnar claw (HP:0001178) | 2.05340123 |
| 83 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.05259798 |
| 84 | Limb dystonia (HP:0002451) | 2.03504373 |
| 85 | Alacrima (HP:0000522) | 2.01623236 |
| 86 | Hepatoblastoma (HP:0002884) | 2.00752872 |
| 87 | Amblyopia (HP:0000646) | 2.00326595 |
| 88 | Difficulty running (HP:0009046) | 1.99482180 |
| 89 | Myotonia (HP:0002486) | 1.97082672 |
| 90 | Hammertoe (HP:0001765) | 1.95818015 |
| 91 | Annular pancreas (HP:0001734) | 1.95529447 |
| 92 | Bowel incontinence (HP:0002607) | 1.94949446 |
| 93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.94452174 |
| 94 | Hypoplasia of the brainstem (HP:0002365) | 1.93465396 |
| 95 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.93465396 |
| 96 | Postural tremor (HP:0002174) | 1.93137393 |
| 97 | Dialeptic seizures (HP:0011146) | 1.92768214 |
| 98 | Shallow orbits (HP:0000586) | 1.92586668 |
| 99 | Aqueductal stenosis (HP:0002410) | 1.89760012 |
| 100 | Lower limb asymmetry (HP:0100559) | 1.88960362 |
| 101 | Flat cornea (HP:0007720) | 1.88309002 |
| 102 | Renovascular hypertension (HP:0100817) | 1.88261117 |
| 103 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.88152184 |
| 104 | Subaortic stenosis (HP:0001682) | 1.88152184 |
| 105 | Abnormality of the foot musculature (HP:0001436) | 1.87804529 |
| 106 | Cortical dysplasia (HP:0002539) | 1.86597928 |
| 107 | Aplasia involving bones of the extremities (HP:0009825) | 1.86102367 |
| 108 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.86102367 |
| 109 | Aplasia of the phalanges of the hand (HP:0009802) | 1.86102367 |
| 110 | Sacral dimple (HP:0000960) | 1.85504425 |
| 111 | Hyperventilation (HP:0002883) | 1.84871594 |
| 112 | Decreased motor nerve conduction velocity (HP:0003431) | 1.84172777 |
| 113 | Exercise-induced muscle cramps (HP:0003710) | 1.83260023 |
| 114 | Renal duplication (HP:0000075) | 1.82960877 |
| 115 | Ventricular fibrillation (HP:0001663) | 1.82579672 |
| 116 | Agitation (HP:0000713) | 1.82483226 |
| 117 | Abnormality of the aortic arch (HP:0012303) | 1.80816625 |
| 118 | Bundle branch block (HP:0011710) | 1.80685977 |
| 119 | Spastic tetraplegia (HP:0002510) | 1.80344855 |
| 120 | Buphthalmos (HP:0000557) | 1.80335430 |
| 121 | Foot dorsiflexor weakness (HP:0009027) | 1.80059781 |
| 122 | Trigonocephaly (HP:0000243) | 1.78719331 |
| 123 | Focal dystonia (HP:0004373) | 1.78650823 |
| 124 | Disinhibition (HP:0000734) | 1.78276236 |
| 125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76781086 |
| 126 | Progressive inability to walk (HP:0002505) | 1.76396583 |
| 127 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.74687591 |
| 128 | Impaired smooth pursuit (HP:0007772) | 1.74150392 |
| 129 | Gaze-evoked nystagmus (HP:0000640) | 1.73854493 |
| 130 | Neoplasm of the heart (HP:0100544) | 1.71514251 |
| 131 | Bradykinesia (HP:0002067) | 1.70945525 |
| 132 | Dysmetric saccades (HP:0000641) | 1.70499824 |
| 133 | Clonus (HP:0002169) | 1.69474979 |
| 134 | Arnold-Chiari malformation (HP:0002308) | 1.67750062 |
| 135 | Arterial tortuosity (HP:0005116) | 1.65668561 |
| 136 | Absent speech (HP:0001344) | 1.65240739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.49650745 |
| 2 | MAP3K9 | 3.76005513 |
| 3 | CASK | 3.51787471 |
| 4 | NTRK3 | 2.61839039 |
| 5 | PAK6 | 2.54732941 |
| 6 | EPHA4 | 2.32128278 |
| 7 | NTRK2 | 2.29577676 |
| 8 | MINK1 | 2.29363730 |
| 9 | PRKD3 | 2.23161729 |
| 10 | MAP3K4 | 2.20076627 |
| 11 | KSR2 | 2.15165236 |
| 12 | SIK2 | 1.96713340 |
| 13 | CAMKK1 | 1.93721931 |
| 14 | DAPK2 | 1.90033322 |
| 15 | TRIB3 | 1.85699438 |
| 16 | PHKG1 | 1.81937547 |
| 17 | PHKG2 | 1.81937547 |
| 18 | TYRO3 | 1.81485002 |
| 19 | NTRK1 | 1.67329084 |
| 20 | KSR1 | 1.60183165 |
| 21 | UHMK1 | 1.55974687 |
| 22 | CAMK1G | 1.53532183 |
| 23 | CDK5 | 1.45928413 |
| 24 | TAOK1 | 1.44690427 |
| 25 | LATS2 | 1.44364538 |
| 26 | EPHA3 | 1.38425781 |
| 27 | MAPK13 | 1.35295954 |
| 28 | RET | 1.32640280 |
| 29 | MARK2 | 1.29035903 |
| 30 | ICK | 1.28389084 |
| 31 | SGK2 | 1.27401210 |
| 32 | FES | 1.25843582 |
| 33 | PINK1 | 1.25556966 |
| 34 | EEF2K | 1.24328675 |
| 35 | RIPK1 | 1.23242955 |
| 36 | DMPK | 1.22170483 |
| 37 | ALK | 1.18283699 |
| 38 | CSNK1G2 | 1.13884629 |
| 39 | BCR | 1.11380763 |
| 40 | CAMK2B | 1.10663472 |
| 41 | DYRK1B | 1.10619506 |
| 42 | MAP2K4 | 1.08925189 |
| 43 | FGFR2 | 1.08051166 |
| 44 | CDK19 | 1.06872174 |
| 45 | MAP2K7 | 1.06097928 |
| 46 | LMTK2 | 1.05876750 |
| 47 | PKN2 | 1.05402838 |
| 48 | STK11 | 1.03578259 |
| 49 | PNCK | 0.95507569 |
| 50 | PRKCH | 0.95298381 |
| 51 | STK38 | 0.94820622 |
| 52 | OBSCN | 0.94049348 |
| 53 | EPHB2 | 0.93874828 |
| 54 | CDK15 | 0.92287748 |
| 55 | SGK223 | 0.92173961 |
| 56 | SGK494 | 0.92173961 |
| 57 | CDK18 | 0.89701943 |
| 58 | CDK14 | 0.88507620 |
| 59 | MAP3K2 | 0.86406120 |
| 60 | CAMK2G | 0.81969404 |
| 61 | CDK11A | 0.81840545 |
| 62 | MAP3K7 | 0.80748204 |
| 63 | CAMK1D | 0.79436838 |
| 64 | PAK3 | 0.76267563 |
| 65 | CAMK1 | 0.76146822 |
| 66 | CSNK1A1L | 0.75570626 |
| 67 | PDGFRA | 0.75324223 |
| 68 | EPHB1 | 0.75180024 |
| 69 | MAPKAPK5 | 0.74224775 |
| 70 | SCYL2 | 0.73908467 |
| 71 | RPS6KA2 | 0.72500676 |
| 72 | CSNK1G3 | 0.70441426 |
| 73 | RIPK4 | 0.70277340 |
| 74 | WNK1 | 0.70271491 |
| 75 | PKN1 | 0.69628125 |
| 76 | LIMK1 | 0.69588520 |
| 77 | NEK6 | 0.68655663 |
| 78 | DYRK2 | 0.67074715 |
| 79 | CAMKK2 | 0.66729952 |
| 80 | PDPK1 | 0.65505514 |
| 81 | SGK3 | 0.64749684 |
| 82 | PRKD1 | 0.64344429 |
| 83 | PLK2 | 0.63442059 |
| 84 | FYN | 0.62625513 |
| 85 | ROCK2 | 0.62165113 |
| 86 | PRKCG | 0.61102112 |
| 87 | GRK5 | 0.60685399 |
| 88 | PDK1 | 0.60350769 |
| 89 | DAPK1 | 0.59196174 |
| 90 | PRKCZ | 0.58926277 |
| 91 | TNIK | 0.57599060 |
| 92 | ERBB2 | 0.57192847 |
| 93 | SGK1 | 0.56349575 |
| 94 | PDGFRB | 0.54902815 |
| 95 | CAMK4 | 0.54865616 |
| 96 | CAMK2D | 0.53567349 |
| 97 | TNK2 | 0.53272812 |
| 98 | MAPK12 | 0.52596982 |
| 99 | PRPF4B | 0.52452803 |
| 100 | DYRK1A | 0.52205943 |
| 101 | CAMK2A | 0.50846363 |
| 102 | PTK2B | 0.50557802 |
| 103 | DDR2 | 0.50113400 |
| 104 | MAPK10 | 0.49430904 |
| 105 | BMX | 0.47891830 |
| 106 | RPS6KA3 | 0.46740991 |
| 107 | FGR | 0.46201740 |
| 108 | PRKAA1 | 0.45896163 |
| 109 | ROCK1 | 0.45640323 |
| 110 | PTK6 | 0.45328788 |
| 111 | RAF1 | 0.44903614 |
| 112 | CDC42BPA | 0.43404454 |
| 113 | CSNK1D | 0.42279480 |
| 114 | PRKG1 | 0.41676260 |
| 115 | BRD4 | 0.41658184 |
| 116 | MAP3K6 | 0.39302988 |
| 117 | ERBB3 | 0.38521655 |
| 118 | CSNK1G1 | 0.38456627 |
| 119 | MAPK8 | 0.36342912 |
| 120 | ARAF | 0.34733017 |
| 121 | WNK3 | 0.34179030 |
| 122 | GSK3B | 0.33807384 |
| 123 | MAPK4 | 0.33255061 |
| 124 | MAP3K11 | 0.32282227 |
| 125 | MAPK9 | 0.28888823 |
| 126 | RPS6KB1 | 0.28143210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.26889521 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.11877542 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.09901133 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.08805324 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.04467898 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 1.99339393 |
| 7 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.98420157 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 1.93539504 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.83862732 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 1.82334934 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.74718131 |
| 12 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.71000459 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70576975 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.67444983 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.65182570 |
| 16 | Axon guidance_Homo sapiens_hsa04360 | 1.59317141 |
| 17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.58885675 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52317070 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50582973 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50355460 |
| 21 | Glioma_Homo sapiens_hsa05214 | 1.50250927 |
| 22 | Gap junction_Homo sapiens_hsa04540 | 1.47357385 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.46063641 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.43685741 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41781341 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.38116625 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37379043 |
| 28 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.35135440 |
| 29 | Insulin secretion_Homo sapiens_hsa04911 | 1.33936654 |
| 30 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.25966758 |
| 31 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23418958 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20818103 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17718325 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17170667 |
| 35 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.16880709 |
| 36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.16699606 |
| 37 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.15634194 |
| 38 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.15429890 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15134067 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.15101916 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13166299 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.11054655 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06966378 |
| 44 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06795667 |
| 45 | Colorectal cancer_Homo sapiens_hsa05210 | 1.06720195 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06411048 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05608988 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05502791 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04901283 |
| 50 | Melanogenesis_Homo sapiens_hsa04916 | 1.04473679 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03851203 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.02782772 |
| 53 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01943514 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00426583 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99990374 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97641972 |
| 57 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97361912 |
| 58 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96855374 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.96606245 |
| 60 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.96276137 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93154065 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.91849623 |
| 63 | * Endocytosis_Homo sapiens_hsa04144 | 0.91705519 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.90441820 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.90291770 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.90053109 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85712371 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84111056 |
| 69 | Bile secretion_Homo sapiens_hsa04976 | 0.83810940 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79578771 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78382209 |
| 72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78157138 |
| 73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77743264 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.76096470 |
| 75 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75837746 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75799819 |
| 77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74630048 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74514351 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74244276 |
| 80 | Platelet activation_Homo sapiens_hsa04611 | 0.73947237 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73144985 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72889824 |
| 83 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69788258 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69705060 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69669965 |
| 86 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.69442102 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68604672 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67580935 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.66895875 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65341626 |
| 91 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.64404608 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63542334 |
| 93 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.63308278 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62834752 |
| 95 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.62742566 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62536760 |
| 97 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62504510 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62077434 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.60483756 |
| 100 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.58890924 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58345995 |
| 102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55888879 |
| 103 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55376946 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.54865690 |
| 105 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54339363 |
| 106 | Alcoholism_Homo sapiens_hsa05034 | 0.52477116 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51946270 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.51906113 |
| 109 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51039597 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50987099 |
| 111 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50779015 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50538160 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50353111 |
| 114 | Phototransduction_Homo sapiens_hsa04744 | 0.49765926 |
| 115 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.47835351 |
| 116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47220436 |
| 117 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.45975628 |

